Medical Management

Shilpa Bhatia, Ph.D.

Shilpa Bhatia, Ph.D.

**** *** *** **, ********, VA-23228, United States

Contact No. 318-***-**** Email i.d.: acbct2@r.postjobfree.com

Professional Summary

Science professional with extensive experience in research and writing spanning diverse therapeutic

areas. Expertise in scientific communications- preparation of abstracts, posters, manuscripts, summary

reports, slide presentations, grant applications and review of scholarly articles for peer-reviewed journals.

Detail-oriented individual with excellent organizational and time management skills.

Areas of interest

Oncology

Virology

Targeted therapeutics

Metabolic and Inflammatory disorders

Stem cell research

Education

Ph.D. (Major: Cellular Biology) 2011

Louisiana State University Health Sciences Center, Shreveport, LA, USA

Characterization and validation of a novel protein to achieve tumor-specific targeting

Construction of a genetically modified adenoviral vector for receptor-mediated delivery

Use of non-invasive imaging tools to monitor the biodistribution of targeted viral vectors

Evaluation of dendritic cell based immunotherapy using a CD-40 directed viral vector

Application of PET imaging in a MPTP-induced mouse model of Parkinson’s disease

MS (Major: Medical Biotechnology) 2005

Postgraduate Institute of Medical Education and Research, Chandigarh, India

Determination of apoptotic effects of a plant lectin in a non-small cell lung cancer model

BS (Major: Biotechnology) 2003

Kurukshetra University, Kurukshetra, India

Professional experience

Post-doctoral fellow Present

Virginia Commonwealth University, Richmond, VA

Understand the mechanism of novel small-molecule inhibitors in preclinical models

Development of combination strategies to improve the efficacy of oncolytic agents

Use of imaging techniques to determine the uptake of reporter-tagged viral vectors

Other Relevant experience

Teaching experience at undergraduate level

Summer internship in different clinical and research laboratories

Initiatives

Provided hands-on training to the undergraduate students in a research laboratory

1

Shilpa Bhatia, Ph.D.

Taught science and language courses to the underprivileged children

Achievements

Contributor of articles “Breaking Advances: Highlights from Recent Cancer Literature” published

by Cancer Research journal

Independent reviewer for various scientific journals

Platform and poster presentations at various national and international meetings

Publications

Dasgupta S, Menezes ME, Das SK, Emdad L, Janjic A, Bhatia S, Mukhopadhyay ND, Shao C,

Sarkar D, Fisher PB. Novel role of MDA-9/Syntenin in regulating urothelial cell proliferation by

modulating EGFR signaling. Clin Cancer Res. 2013, 19 (17):4621-33.

Bhatia S, Menezes ME, Das SK, Emdad L, Dasgupta S, Wang XY, Sarkar D, Fisher PB.

Innovative approaches for enhancing cancer gene therapy. Discov Med. 2013, 15(84):309-17.

Williams BJ, Bhatia S, Adams LK, Boling SL, Carroll JL, Li XL, Rogers DK, Korokhov N,

Kovesdi I, Pereboev AV, Curiel DT, Mathis JM. Dendritic cell based PSMA immunotherapy for

prostate cancer using a CD-40 targeted adenovirus vector. PLoS one. 2012, 7(10):e46981.

Toomey JS, Bhatia S, Moon LT, Orchard EA, Tainter KH, Terry T, Mathis JM, Penman AD.

PET imaging a MPTP-induced mouse model of Parkinson’s disease using the Fluoropropyl-

Dihydrotetrabenzine analog [18F]-DTBZ (AV-133). PLoS one. 2012, 7 (6): e39041 [Epub 2012

Jun 18].

Coburn MA, Brueggemann S, Bhatia S, Cheng B, Li BD, Li XL, Luraguiz N, Maxuitenko YY,

Orchard EA, Zhang S, Stoff-Khalili MA, Mathis JM, Kleiner-Hancock HE. (2011)

Establishment of a mammary carcinoma cell line from syrian hamsters treated with N -Methyl-N-

Nitrosourea. Cancer Lett. 2011, 312 (1) 82-90 [Epub 2011 Aug 17].

Mathis JM, Bhatia S, Khandelwal A, Kovesdi I, Lokitz SJ, Odaka Y, Takalkar AM, Terry T,

Curiel DT. Genetic incorporation of human metallothionein into the adenovirus protein IX for

non-invasive SPECT imaging. PLoS One. 2011, 6 (2): e16792.

Bhatia S, Emdad L, Das SK, Hamed H, Dent P, Sarkar D, Fisher PB. Non-Braf targeted

therapies for melanoma: Protein kinase inhibitors in Phase II clinical trials. Expert Opin Investig

Drugs. 2013, Submitted.

Bhatia S, Rivera AA, Curiel DT, Mathis JM. CXCR4 retargeting of an adenovirus vector to

breast cancer cells using a bispecific Adapter. Cancer Gene Ther. Under final submission.

Nedeljkovic-Kurepa A, Bhatia S, Curiel DT, Mathis JM. Combination of oncolytic virotherapy

with chemotherapy enhances breast cancer killing. Under final submission.

Book Chapter

Menezes ME*, Bhatia S*, Bhoopathi P, Das SK, Emdad L, Dasgupta S, Dent P, Wang XY,

Sarkar D, Fisher PB. MDA-7/IL-24: Multifunctional Cancer Killing Cytokine. Anticancer Genes.

Springer. Due for publication in July, 2014. *Authors have equal contribution

Certifications and Awards

Distinction certificate in “Writing in Sciences” course (Stanford University, USA)

Best Poster Category award at the Society of Toxicology Meeting

Scholarship by United Schools International in Annual All India UNESCO Information Test

2

Contact this candidate